Tucson, AZ, United States of America

David Squire Thorpe


Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: David Squire Thorpe: Innovator in Pharmaceutical Chemistry

Introduction

David Squire Thorpe is a notable inventor based in Tucson, AZ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors involved in various diseases. With a total of 3 patents, Thorpe's work is instrumental in advancing therapeutic options for patients.

Latest Patents

Thorpe's latest patents include innovative compounds that serve as CXCR3 receptor antagonists. The first patent focuses on cycloalkane carboxylic acid derivatives, which are useful for the preventive or therapeutic treatment of diseases caused by abnormal activation of CXCR3 chemokines. This invention also details a process for preparing these compounds, along with pharmaceutical compositions that incorporate them.

Another significant patent involves substituted benzoylamino-indan-2-carboxylic acids and related compounds. This invention presents novel compounds that exhibit CXCR5 inhibitory activity, making them particularly valuable in treating or preventing inflammatory diseases such as rheumatoid arthritis, multiple sclerosis, lupus, and Crohn's Disease.

Career Highlights

David Squire Thorpe is currently employed at Sanofi, a global leader in the pharmaceutical industry. His work at Sanofi has allowed him to focus on developing innovative solutions that address critical health challenges. Thorpe's expertise in pharmaceutical chemistry has positioned him as a key contributor to the company's research and development efforts.

Collaborations

Throughout his career, Thorpe has collaborated with talented professionals in the field. Notable coworkers include Martin Smrcina and Dagmar Dasha Cabel, who have worked alongside him on various projects aimed at advancing pharmaceutical innovations.

Conclusion

David Squire Thorpe's contributions to pharmaceutical chemistry through his patents and work at Sanofi highlight his commitment to improving healthcare solutions. His innovative compounds have the potential to make a significant impact on the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…